Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
Introduction: atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this treatment is directly related to time in therapeutic range (TTR). This study aimed to report the TTR in patients with non-valvular AF at an a...
Main Authors: | Fernando Pivatto Júnior, André Luis Ferreira da Silva, Bárbara Bárbara Marina Simionato, Fernanda Fuzinatto, Jerônimo De Conto Oliveira, Leonardo Martins Pires, Roberta Cristina Petry, Rafael Selbach Scheffel, Luís Carlos Amon |
---|---|
Format: | Article |
Language: | English |
Published: |
Hospital de Clinicas de Porto Alegre ; Universidade Federal do Rio Grande do Sul (UFRGS)
2014-06-01
|
Series: | Clinical and Biomedical Research |
Subjects: | |
Online Access: | http://seer.ufrgs.br/hcpa/article/view/44802 |
Similar Items
-
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01) -
Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01) -
ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01) -
Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01) -
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
by: Lisette Warkentin, et al.
Published: (2022-05-01)